Kimberley T Lee, Brian D Gonzalez, Carley Geiss, Hayden J Fulton, Dannelle Charles, Susan T Vadaparampil, N Lynn Henry, Heather S L Jim, Dawn L Hershman, Shelley S Tworoger, Clement K Gwede
PURPOSE: Adherence to oral endocrine therapy (ET) remains an issue for up to half of women prescribed these medications. There is emerging data that Black breast cancer survivors (BCS) have lower rates of ET adherence. Given the disparities in breast cancer recurrence and survival for Black BCS compared to their White counterparts, the goal of this study is to better understand barriers to ET adherence among Black BCS from the patient and provider perspectives. METHODS: In this qualitative study, we conducted semi-structured interviews between October 29, 2021, and March 1, 2023...
March 23, 2024: Journal of Cancer Survivorship: Research and Practice